𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroimaging in Alzheimer's Disease: Relevance for the Development of Therapeutic Agents

✍ Scribed by Christopher H. Van Dyck

Book ID
109105543
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
13 KB
Volume
6
Category
Article
ISSN
1080-563X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Advances in the development of kinase in
Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease
✍ Mary J. Savage; Diane E. Gingrich πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

## Abstract Pharmaceutical approaches to slow the progression of Alzheimer's disease (AD) have focused primarily on reducing production or increasing clearance of amyloid Ξ² peptide (AΞ²). Recent clinical trial results question the efficacy of targeting AΞ² for treatment of mild to moderate AD, highli

Review of drug development and therapeut
Review of drug development and therapeutic role of cholinesterase inhibitors in Alzheimer's disease
✍ John J. Sramek; Victoria Zarotsky; Neal R. Cutler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Researchers have for some time appreciated the role of the neurotransmitter acetylcholine in Alzheimer's disease, and have realized the development of a number of acetylcholinesterase inhibitors. Bridging and dynabridging studies have played an important role in the development of these